- Filed
- Jul 10, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Jul 8, 2020 | 37.96M sh |
| Shares Diluted | FY 2020 · Mar 31, 2019 | 28.94M sh |
| Operating Cash Flow | FY 2020 · Mar 31, 2019 | −$5.6M |
| Cash And Equivalents | FY 2020 · Mar 31, 2019 | $9.32M |
| Stockholders Equity | FY 2020 · Mar 31, 2019 | $18.17M |
| Stockholders Equity | FY 2020 · Mar 31, 2018 | $18.86M |
| Current Liabilities | FY 2020 · Mar 31, 2019 | $55.21M |
| Total Liabilities | FY 2020 · Mar 31, 2019 | $55.76M |
| Current Assets | FY 2020 · Mar 31, 2019 | $56.2M |
| Total Assets | FY 2020 · Mar 31, 2019 | $72.73M |
| Eps Diluted | FY 2020 · Mar 31, 2019 | −$0.03 |
| Eps Basic | FY 2020 · Mar 31, 2019 | −$0.03 |
| Sga Expense | FY 2020 · Mar 31, 2019 | $1.72M |
| Net Income restated | FY 2020 · Mar 31, 2019 | −$926.28K |
| Operating Income | FY 2020 · Mar 31, 2019 | −$876.13K |
| Gross Profit | FY 2020 · Mar 31, 2019 | $25.11M |
| Cost Of Revenue | FY 2020 · Mar 31, 2019 | $82.44M |
| Revenue | FY 2020 · Mar 31, 2019 | $107.55M |